The global veterinary oncology market size was valued at USD 1.35 billion in 2025 and is projected to grow from USD 1.49 billion in 2026 to USD 3.34 billion by 2034, registering a CAGR of 10.6% during the forecast period (2026–2034).

The market is experiencing substantial growth due to the increasing prevalence of cancer among companion animals, rising pet ownership, growing expenditure on animal healthcare, and continuous advancements in veterinary cancer diagnostics and treatment technologies. Veterinary oncology has become a critical segment of animal healthcare as pet owners increasingly seek specialized cancer treatment options to improve the quality of life and survival rates of their pets.

Key Highlights

• North America holds the largest share of the global veterinary oncology market.
• Europe is the fastest-growing regional market.
• By therapy, the Chemotherapy segment dominates the market with the largest revenue share.
• By animal type, the Canine segment is the largest and fastest-growing segment.
• By cancer type, Lymphoma accounts for the largest market share.
• Rising awareness regarding pet health and availability of advanced cancer treatment options are accelerating market expansion.

Market Dynamics

Market Driver

The growing incidence of cancer among companion animals is one of the primary factors driving market growth. Similar to humans, pets are increasingly being diagnosed with various forms of cancer due to aging populations, improved diagnostic capabilities, and enhanced awareness among pet owners. As veterinary professionals gain access to advanced diagnostic technologies such as CT scans, MRI systems, molecular diagnostics, and cancer screening tools, early detection rates continue to improve, increasing demand for oncology treatments.

Additionally, rising pet humanization trends and higher spending on companion animal healthcare are fueling the adoption of specialized cancer therapies. Pet owners are increasingly willing to invest in advanced treatments including chemotherapy, immunotherapy, radiation therapy, and targeted therapies, creating significant growth opportunities for veterinary oncology service providers and pharmaceutical companies.

Market Restraint

Despite favorable growth prospects, the high cost associated with veterinary cancer diagnosis and treatment remains a major challenge. Advanced oncology procedures, specialized equipment, and long-term treatment protocols can create substantial financial burdens for pet owners, limiting treatment adoption rates in several developing and emerging markets.

Furthermore, the shortage of trained veterinary oncologists and limited availability of specialized cancer treatment facilities in certain regions may restrict market growth. Lack of awareness regarding advanced veterinary oncology solutions also continues to hinder adoption in underserved areas.

Market Opportunity

Rapid advancements in veterinary cancer therapeutics present significant opportunities for market expansion. The development of targeted therapies, precision medicine, immunotherapies, and personalized treatment approaches is transforming veterinary oncology and improving treatment outcomes.

Growing investments in veterinary research, increasing clinical trials for animal cancer therapies, and the introduction of innovative diagnostic tests are expected to create lucrative opportunities for market participants. Emerging markets with expanding pet populations and improving veterinary infrastructure are also expected to contribute significantly to future market growth.

Top Market Players

• PetCure Oncology
• Accuray Incorporated
• Varian Medical Systems
• Boehringer Ingelheim
• Elanco
• Zoetis
• Karyopharm Therapeutics, Inc.
• IDEXX Laboratories
• ELIAS Animal Health
• FidoCure

Market Segmentation

By Therapy

• Surgery
• Radiology
• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Others

By Animal Type

• Canine
• Feline
• Others

By Cancer Type

• Lymphoma
• Mast Cell Cancer
• Mammary and Squamous Cell Cancer
• Others

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Middle East & Africa
• Latin America (LATAM)

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/veterinary-oncology-market

The Veterinary Oncology Market report provides comprehensive insights into market size, growth trends, competitive landscape, regional outlook, emerging technologies, investment opportunities, strategic developments, and future industry prospects. The report helps stakeholders make informed business decisions through detailed market intelligence and actionable insights.

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights and market research reports.

Contact Us

Email: sales@straitsresearch.com

Tel:
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)